BRANDI MOORE: Open Payments
NPI 1528041381 · MAX MEADOWS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$693 in 41 payments from 10 companies in 2025. Trend: 2023 $22 · 2024 $385 · 2025 $693
Food & beverage: $693
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $293 |
| Gilead Sciences, Inc. | 15 | $141 |
| Madrigal Pharmaceuticals | 3 | $87 |
| Ardelyx, Inc. | 3 | $61 |
| Novo Nordisk Inc | 1 | $27 |
| Celltrion USA Inc. | 1 | $26 |
| PFIZER INC. | 1 | $19 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $10 |
Products named: RINVOQ, REZDIFFRA, IBSRELA, MAVYRET, Wegovy, VEGZELMA, SKYRIZI, VELSIPITY.
Industry payments across VA — which companies pay providers there.
